Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 01, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Reports Fiscal Year 2012 Financial Highlights and Program Updates

NOVATO, Calif., Nov. 1, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the Company") (Nasdaq:RPTP) today announced its fiscal year 2012 ended August 31, 2012 financial highlights,...
October 17, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Announces Presentation of PROCYSBI(TM) (RP103) Extension Study Data at the ASN Annual Meeting

NOVATO, Calif., Oct. 17, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), announced that Craig B. Langman, M.D., Head of Kidney Diseases, and the Isaac...
October 10, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Obtains Tissue Fibrotic Disease Intellectual Property Related to Cysteamine

NOVATO, Calif., Oct. 10, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that the Company has acquired exclusive world-wide rights to...
September 10, 2012 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Expands Senior Management

NOVATO, Calif., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced the appointment of Georgia Erbez, as Chief Financial Officer...
August 30, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at the Stifel Nicolaus Healthcare Conference 2012

NOVATO, Calif., Aug. 30, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that Christopher M. Starr, Ph.D., Chief Executive Officer of...
August 07, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at Two Upcoming Investor Conferences

NOVATO, Calif., Aug. 7, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that Ted Daley, President of Raptor, will present an overview of...
July 30, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Announces Issuance of Key European Patent Protecting the Cysteamine Portfolio

NOVATO, Calif., July 30, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that the European Patent Office has issued a key patent...
July 11, 2012 17:40 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Announces Third Quarter Fiscal 2012 Financial Results

NOVATO, Calif., July 11, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today provided an update on the Company's business and announced financial...
July 05, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at the Seventh Annual JMP Securities Healthcare Conference

NOVATO, Calif., July 5, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that Patrice P. Rioux, M.D., Ph.D., Chief Medical Officer of...
June 25, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Begins Dosing in Phase 2b Trial of RP103 for Non-Alcoholic Steatohepatitis ("NASH")

NOVATO, Calif., June 25, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that a first patient has been dosed in its Phase 2b clinical...